Skip to main content
. 2013 Jul 4;67:398–408. doi: 10.1016/j.ejmech.2013.06.053

Table 2.

Anti-cytomegalovirus activity and cytotoxicity of compound 31 in human embryonic lung (Hel) cells.

Compound EC50a (μM) AD-169 strain CC50b (μM)
31 9.9 ± 1.0 100
Ganciclovir 8.2 ± 0.3 >350
Cidofovir 1.0 ± 0.14 >350
a

50% Effective concentration or compound concentration required to inhibit virus-induced cytopathicity by 50%.

b

50% Cytotoxic concentration or compound concentration required to reduce the viability of Hel cells by 50%.